BPC-157 vs TB-500
A side-by-side research comparison of BPC-157 and TB-500 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | BPC-157 | TB-500 |
|---|---|---|
| Full name | Body Protection Compound-157 | Thymosin Beta-4 (Synthetic) |
| Category | Healing & Recovery | Healing & Recovery |
| Status | Research compound | Research compound |
| Mechanism | Upregulates growth factor expression including VEGF and promotes angiogenesis, modulates nitric oxide system, and interacts with the dopaminergic system. | Upregulates actin production to promote cell migration and proliferation, enhances angiogenesis, and reduces pro-inflammatory cytokines. |
| Molecular weight | 1419.53 Da | 4921 Da |
| Half-life | ~4 hours | ~6 hours |
| Bioavailability | Variable; oral and injectable forms available | ~95% via subcutaneous injection |
| Typical dose | 250-500 mcg per dose | 2-5 mg per dose |
| Frequency | 1-2x daily | Loading: 2x/week · Maintenance: 1x/week |
| Route | Subcutaneous injection (or oral capsules) | Subcutaneous injection |
BPC-157 reported benefits
- Accelerated tendon and ligament healing
- Gut lining protection and repair
- Neuroprotective effects
- Anti-inflammatory properties
- Muscle tear recovery
TB-500 reported benefits
- Enhanced wound healing
- Reduced inflammation
- Improved flexibility
- Cardiac tissue repair
- Hair regrowth support
Related comparisons
Research and educational reference only. Not medical advice.